USANA Health Sciences, Inc. (USNA)
For informational purposes only. Not financial advice. Analysis by Sedat Aydin, Founder & Editor-in-Chief | AI-powered analysis. Data sourced from SEC filings and institutional-grade financial providers. Editorially reviewed. Not financial advice.
USNA represents USANA Health Sciences, Inc., a Consumer Defensive business priced at $17.01 (market cap $313.95M). The stock scores 50/100, a moderate rating based on 9 quantitative KPIs.
Last analyzed: 2026年2月8日USANA Health Sciences, Inc. (USNA) Consumer Business Overview
USANA Health Sciences offers investors a notable opportunity to tap into the growing health and wellness market through its direct-selling model and science-backed nutritional products, targeting diverse age groups and health needs with a strong presence in Asia Pacific.
Investment Thesis
Investing in USANA Health Sciences presents a notable opportunity due to the company's established presence in the growing nutritional and personal care market. With a market capitalization of $0.39 billion and a gross margin of 76.1%, USANA demonstrates financial stability and profitability. The company's direct-selling model provides a scalable distribution network, particularly in the Asia Pacific region, which represents a significant growth driver. The company's commitment to science-based formulations and research collaborations, such as the agreement with Beijing University of Chinese Medicine, enhances its credibility and product differentiation. USANA's P/E ratio of 22.94 suggests a reasonable valuation relative to its earnings. Continued expansion in key markets and innovation in product development are expected to drive revenue growth and shareholder value.
Based on FMP financials and quantitative analysis
Key Highlights
- Gross Margin of 76.1% indicates strong pricing power and efficient cost management.
- Market Cap of $0.39B reflects the company's current valuation in the market.
- P/E Ratio of 22.94 suggests a reasonable valuation compared to its earnings.
- Presence in Asia Pacific, the Americas, and Europe provides geographic diversification.
- Direct-selling model enables scalable distribution and entrepreneurial opportunities.
Competitors & Peers
Strengths
- Science-backed product formulations.
- Direct-selling distribution model.
- Global presence in key markets.
- Strong brand reputation.
Weaknesses
- Reliance on direct-selling model can be susceptible to regulatory changes.
- Profit margin of 1.9% is relatively low compared to peers.
- Limited dividend payout may deter some investors.
- Potential for negative publicity related to direct-selling practices.
Catalysts
- Expansion into new geographic markets, particularly in Asia Pacific.
- Product innovation and development of new supplement formulations.
- Launch of new e-commerce initiatives to drive online sales.
- Strategic partnerships with healthcare providers and wellness influencers.
Risks
- Regulatory changes affecting the direct-selling industry.
- Negative publicity related to product safety or efficacy.
- Economic downturns impacting consumer spending on discretionary items.
- Intense competition from other nutritional supplement companies.
- Fluctuations in currency exchange rates affecting international sales.
Growth Opportunities
- Expansion in Asia Pacific: USANA has a significant opportunity to further expand its presence in the Asia Pacific region, where demand for nutritional supplements and personal care products is rapidly growing. The region's large population and increasing disposable incomes create a favorable market for USANA's products. By strengthening its distribution network and tailoring its product offerings to local preferences, USANA can capture a larger share of this market.
- Product Innovation: Investing in research and development to create innovative and science-backed products can drive growth. The company's research collaboration agreement with Beijing University of Chinese Medicine can lead to the development of new products based on traditional Chinese medicine, which could appeal to a broader customer base. New products targeting specific health needs or age groups can also attract new customers and increase sales.
- E-commerce Growth: Enhancing its online presence and e-commerce capabilities can enable USANA to reach a wider audience and increase sales. Investing in user-friendly website design, mobile apps, and digital marketing can improve the customer experience and drive online sales. Offering personalized product recommendations and subscription services can also enhance customer loyalty and increase repeat purchases.
- Personalized Nutrition: The growing trend of personalized nutrition offers a significant growth opportunity for USANA. By offering customized supplement recommendations based on individual health needs and preferences, USANA can differentiate itself from competitors and attract customers seeking personalized solutions. This can be achieved through online assessments, DNA testing, and consultations with healthcare professionals.
- Strategic Partnerships: Forming strategic partnerships with healthcare providers, fitness centers, and wellness influencers can expand USANA's reach and credibility. Collaborating with these partners to promote USANA's products and educate consumers about the benefits of nutrition and personal care can drive sales and brand awareness. These partnerships can also provide access to new customer segments and distribution channels.
Opportunities
- Expansion in emerging markets.
- Development of personalized nutrition products.
- Increased focus on e-commerce and digital marketing.
- Strategic partnerships with healthcare providers.
Threats
- Intense competition in the nutritional supplement industry.
- Changing consumer preferences and trends.
- Regulatory scrutiny of direct-selling practices.
- Economic downturns affecting consumer spending.
Competitive Advantages
- Science-based formulations: Focus on research and development provides a competitive edge.
- Direct-selling model: Creates a loyal customer base and scalable distribution network.
- Global presence: Diversifies revenue streams and reduces reliance on any single market.
- Brand reputation: Established brand with a reputation for quality and efficacy.
About USNA
USANA Health Sciences, Inc., founded in 1992 and headquartered in Salt Lake City, Utah, is a developer, manufacturer, and direct seller of science-based nutritional and personal care products. The company's foundation lies in its commitment to providing high-quality supplements and skincare solutions designed to enhance overall health and well-being. USANA's product portfolio includes USANA nutritional products, featuring essentials/CellSentials, vitamin and mineral supplements catering to various age groups, and optimizers, targeted supplements addressing cardiovascular, skeletal/structural, and digestive health needs. Additionally, the company offers a range of foods, including meal replacement shakes and snack bars. Expanding beyond nutrition, USANA provides Celavive, a comprehensive skin care regimen formulated for diverse skin types and ethnicities. The company also offers specialized products for prenatal, infant, and young child age groups, demonstrating its commitment to supporting health at every stage of life. USANA operates through a direct-selling model, empowering associates to build their own businesses by marketing and distributing the company's products. The company supports its associates with materials and online tools to facilitate business development and product promotion. USANA's products are available directly in the Asia Pacific, the Americas, and Europe, as well as through online channels, reflecting its global reach and accessibility. USANA has a research collaboration agreement with Beijing University of Chinese Medicine for research in the field of traditional Chinese medicine and National Sports Training Bureau.
What They Do
- Develops and manufactures science-based nutritional supplements.
- Offers a range of vitamin and mineral supplements for various age groups.
- Provides targeted supplements for cardiovascular, skeletal, and digestive health.
- Produces meal replacement shakes and snack bars.
- Offers Celavive skin care products for different skin types and ethnicities.
- Sells products directly through associates in Asia Pacific, the Americas, and Europe.
- Provides online tools and materials to assist associates in building their businesses.
Business Model
- Direct selling: Products are sold through a network of independent distributors.
- Product sales: Revenue is generated from the sale of nutritional and personal care products.
- Global operations: Operates in multiple countries across Asia Pacific, the Americas, and Europe.
Industry Context
USANA Health Sciences operates within the competitive packaged foods and dietary supplements industry, which is experiencing growth driven by increasing consumer awareness of health and wellness. The global dietary supplements market is projected to reach billions of dollars in the coming years. Key trends include the rising demand for personalized nutrition, clean label products, and e-commerce channels. USANA differentiates itself through its science-based formulations, direct-selling model, and global presence, particularly in the Asia Pacific region. Competitors include companies like BGS, BRCC, CVGW, DDL, and LND, which compete for market share through various distribution channels and product offerings.
Key Customers
- Individuals seeking nutritional supplements for overall health and wellness.
- Customers looking for targeted supplements for specific health needs.
- Individuals interested in science-based skin care products.
- Associates who purchase products for personal use and resale.
Financials
Chart & Info
USANA Health Sciences, Inc. (USNA) stock price: $17.01 (+0.00, +0.00%)
Latest News
-
Protein Pop Launches Protein Pop Plus at Costco Nationwide
Yahoo! Finance: USNA News · 2026年2月25日
-
The Top 5 Analyst Questions From USANA’s Q4 Earnings Call
Yahoo! Finance: USNA News · 2026年2月24日
-
USNA or UTHR: Which Is the Better Value Stock Right Now?
Yahoo! Finance: USNA News · 2026年2月23日
-
Is Amneal Pharmaceuticals (AMRX) Stock Undervalued Right Now?
Yahoo! Finance: USNA News · 2026年2月23日
Analyst Consensus
Consensus Rating
Aggregated Buy/Hold/Sell recommendations from Benzinga, Yahoo Finance, and Finnhub for USNA.
Price Targets
Consensus target: $39.00
MoonshotScore
What does this score mean?
The MoonshotScore rates USNA's growth potential on a scale of 0-100 across multiple factors including innovation, market disruption, financial health, and momentum.
Competitors & Peers
Latest News
Protein Pop Launches Protein Pop Plus at Costco Nationwide
The Top 5 Analyst Questions From USANA’s Q4 Earnings Call
USNA or UTHR: Which Is the Better Value Stock Right Now?
Is Amneal Pharmaceuticals (AMRX) Stock Undervalued Right Now?
What Investors Ask About USANA Health Sciences, Inc. (USNA)
What are the key factors to evaluate for USNA?
USANA Health Sciences, Inc. (USNA) currently holds an AI score of 50/100, indicating moderate score. The stock trades at a P/E of 24.2x, near the S&P 500 average (~20-25x). Analysts target $39.00 (+129% from $17.01). Key strength: Science-backed product formulations. Primary risk to monitor: Regulatory changes affecting the direct-selling industry. This is not financial advice.
How frequently does USNA data refresh on this page?
USNA prices update in real time during U.S. market hours (9:30 AM-4:00 PM ET, weekdays). Fundamentals refresh after quarterly or annual filings. Analyst ratings and AI insights update daily. News is aggregated continuously from financial sources.
What has driven USNA's recent stock price performance?
Recent price movement in USANA Health Sciences, Inc. (USNA) can be influenced by earnings results, analyst revisions, sector rotation, and broader market sentiment. The current analyst target of $39.00 implies 129% upside from here. Notable catalyst: Science-backed product formulations. Check the News and Technical Analysis tabs for the latest drivers. Past performance does not predict future results.
Should investors consider USNA overvalued or undervalued right now?
Determining whether USANA Health Sciences, Inc. (USNA) is overvalued or undervalued requires examining multiple metrics. Its P/E ratio is 24.2. Analysts target $39.00 (+129% from current price), suggesting analysts see upside potential. Compare valuation ratios (P/E, P/S, EV/EBITDA) against sector peers for a comprehensive view.
What research should beginners do before buying USNA?
Before investing in USANA Health Sciences, Inc. (USNA), research these four areas: (1) the company's revenue model and competitive position (see Company Overview), (2) financial health through revenue growth, margins, and cash flow (see MoonshotScore), (3) what Wall Street analysts recommend and their price targets (see Analyst tab), and (4) specific risk factors that could impact the stock (see Risk Factors section).
Why might investors consider adding USNA to a portfolio?
Potential reasons to consider USANA Health Sciences, Inc. (USNA) depend on individual investment goals and risk tolerance. A key strength identified by analysis: Science-backed product formulations. Additionally: Direct-selling distribution model. Always weigh potential rewards against risks and diversify across holdings. This is not financial advice.
Can I buy fractional shares of USNA?
Yes, most major brokerages offer fractional shares of USANA Health Sciences, Inc. (USNA) with no minimum purchase requirement. This means you can invest any dollar amount regardless of the share price. Check your brokerage platform for specific terms, fees, and fractional share availability.
How can I track USNA's earnings and financial reports?
USANA Health Sciences, Inc. (USNA) reports quarterly earnings approximately 4-6 weeks after each fiscal quarter ends. You can track earnings dates, revenue and EPS estimates, and actual results on this page's Financials tab. Earnings surprises (beats or misses) often cause significant short-term price moves. Setting up alerts through your brokerage for USNA earnings announcements is recommended.
Disclaimer: This content is for informational purposes only and does not constitute investment advice. Always do your own research and consult a financial advisor.
Official Resources
Data provided for informational purposes only.
- Stock data pending update may affect valuation metrics.
- Direct-selling business model inherently carries regulatory risk.